Targeted delivery of doxorubicin and therapeutic FOXM۱ aptamer to tumor cells using gold nanoparticles modified with AS۱۴۱۱ and ATP aptamers

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 81

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-26-10_008

تاریخ نمایه سازی: 4 شهریور 1402

Abstract:

Objective(s): A targeted delivery platform was prepared to co-deliver both doxorubicin (Dox) as an anticancer drug and FOXM۱ aptamer as a therapeutic substance to breast cancer cells (۴T۱ and MCF-۷) to reduce Dox side effects and increase its therapeutic efficacy. The targeted system (AuNPs-AFPA) consisted of FOXM۱ aptamer, AS۱۴۱۱ aptamer (targeting oligonucleotide), ATP aptamer, and gold nanoparticles (AuNPs) as a carrier.Materials and Methods: AuNPs were synthesized by reduction of HAuCl۴. Next, after pegylation of ATP aptamer, FOXM۱ aptamer-PEGylated ATP aptamer conjugate (FPA) was prepared. Then, the AS۱۴۱۱ aptamer and FPA were exposed to the AuNPs surface through their thiol groups. Subsequently, Dox was loaded into the complex to form a targeted therapeutic complex.Results: The data of the MTT assay displayed that the targeted complex could remarkably reduce cell viability rate in target cells due to the overexpression of nucleolin on their cell membranes compared to nontarget cells, showing the targeting ability of AuNPs-AFPA-Dox. The in vivo antitumor effect confirmed that AuNPs-AFPA-Dox was capable of remarkably diminishing tumor growth relative to the free Dox in mice bearing ۴T۱ tumor cells. Conclusion: The results confirmed that the targeted system improved the therapeutic effect by loading high amounts of Dox alongside the presence of the therapeutic effect of FOXM۱ aptamer. Finally, it can be concluded that AuNPs-AFPA-Dox by enhancing antitumor effectiveness and reducing toxicity toward non-target cells, can be used potentially as an effective strategy for the treatment of breast cancer.v

Authors

Aref Abdollahzade

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Hoda Rahimi

School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Elnaz Yaghoobi

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mohammad Ramezani

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Mona Alibolandi

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Khalil Abnous

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

Seyed Mohammad Taghdisi

Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, ...
  • Abdalkareem Jasim S, Zedan Khalaf O, Hamoud Alshahrani S, Hachem ...
  • Atlan M, Neman J. Targeted transdermal delivery of curcumin for ...
  • Turato C, Balasso A, Carloni V, Tiribelli C, Mastrotto F, ...
  • Ghanghoria R, Kesharwani P, Tekade RK, Jain NK. Targeting luteinizing ...
  • Turato C, Balasso A, Carloni V, Tiribelli C, Mastrotto F, ...
  • Liu P, Zhang R, Yu W, Ye Y, Cheng Y, ...
  • Wang Z, Deng X, Ding J, Zhou W, Zheng X, ...
  • Jalalian SH, Taghdisi SM, Shahidi Hamedani N, Kalat SA, Lavaee ...
  • Yung BC, Li J, Zhang M, Cheng X, Li H, ...
  • Farhangfar S, Fesahat F, Zare-Zardini H, Dehghan-Manshadi M, Zare F, ...
  • Khan A, Rashid R, Murtaza G, Zahra A. Gold nanoparticles: ...
  • Danesh NM, Lavaee P, Ramezani M, Abnous K, Taghdisi SM. ...
  • Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug ...
  • Pishavar E, Yazdian-Robati R, Abnous K, Hashemi M, Ebrahimian M, ...
  • Bayat P, Nosrati R, Alibolandi M, Rafatpanah H, Abnous K, ...
  • Tang X, Wang Y-S, Xue J-H, Zhou B, Cao J-X, ...
  • Abnous K, Danesh NM, Ramezani M, Charbgoo F, Bahreyni A, ...
  • Xiang Q, Tan G, Jiang X, Wu K, Tan W, ...
  • Barati Farimani A, Dibaeinia P, Aluru NR. DNA origami–graphene hybrid ...
  • Abnous K, Danesh NM, Ramezani M, Yazdian-Robati R, Alibolandi M, ...
  • Jiang Q, Zhao S, Liu J, Song L, Wang ZG, ...
  • Dapić V, Bates PJ, Trent JO, Rodger A, Thomas SD, ...
  • Dam DH, Lee JH, Sisco PN, Co DT, Zhang M, ...
  • Yaghoobi E, Zavvar T, Ramezani M, Alibolandi M, Oskuei S, ...
  • Li F, Lu J, Liu J, Liang C, Wang M, ...
  • Taghdisi SM, Danesh NM, Ramezani M, Yazdian-Robati R, Abnous K. ...
  • Yaghoobi E, Shojaee S, Ramezani M, Alibolandi M, Charbgoo F, ...
  • Halasi M, Gartel AL. Suppression of FOXM۱ sensitizes human cancer ...
  • Urata H, Nomura K, Wada S, Akagi M. Fluorescent-labeled single-strand ...
  • Sameiyan E, Bagheri E, Dehghani S, Ramezani M, Alibolandi M, ...
  • Mo R, Jiang T, DiSanto R, Tai W, Gu Z. ...
  • Zhou F, Wang P, Peng Y, Zhang P, Huang Q, ...
  • Storhoff JJ, Elghanian R, Mucic RC, Mirkin CA, Letsinger RL. ...
  • Danesh NM, Lavaee P, Ramezani M, Abnous K, Taghdisi SM. ...
  • Abnous K, Danesh NM, Ramezani M, Alibolandi M, Bahreyni A, ...
  • Khademi Z, Lavaee P, Ramezani M, Alibolandi M, Abnous K, ...
  • Dassie JP, Giangrande PH. Current progress on aptamer-targeted oligonucleotide therapeutics. ...
  • Nuzzo S, Catuogno S, Capuozzo M, Fiorelli A, Swiderski P, ...
  • Kopeckova K, Eckschlager T, Sirc J, Hobzova R, Plch J, ...
  • Morales-Cruz M, Delgado Y, Castillo B, Figueroa CM, Molina AM, ...
  • Li X, Wang L, Fan Y, Feng Q, Cui F-z. ...
  • Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, ...
  • Gopinath K, Gowri S, Karthika V, Arumugam A. Green synthesis ...
  • Gopinath SC, Lakshmipriya T, Awazu K. Colorimetric detection of controlled ...
  • Liu J, Guan Z, Lv Z, Jiang X, Yang S, ...
  • Chung CH, Kim JH, Jung J, Chung BH. Nuclease-resistant DNA ...
  • Yehl K, Joshi JP, Greene BL, Dyer RB, Nahta R, ...
  • Yazdian-Robati R, Ramezani M, Jalalian SH, Abnous K, Taghdisi SM. ...
  • Bagalkot V, Farokhzad OC, Langer R, Jon S. An aptamer-doxorubicin ...
  • Cheng W, Liang C, Wang X, Tsai HI, Liu G, ...
  • Porciani D, Tedeschi L, Marchetti L, Citti L, Piazza V, ...
  • Nejabat M, Mohammadi M, Abnous K, Taghdisi SM, Ramezani M, ...
  • Kalyanaraman B. Teaching the basics of the mechanism of doxorubicin-induced ...
  • نمایش کامل مراجع